The clinical presentation of chronic hepatitis B virus infection in Asian Americans: A single center retrospective study

Journal of Clinical Gastroenterology

Volumn 44, Issue 5, 2010, Pages 364-370

  Mellen, Jonathan S ^a   Xia, Victor W ^b   Hashemzadeh, Mehrtash ^c   Imagawa, David ^d   Jamal, Mazen ^a   Hoefs, John ^a   Hu, Ke Qin ^a  

^a Chao Comprehensive Digestive Disease Center   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Asian Americans; Chronic hepatitis B; HBV infection; Hepatic fibrosis; Hepatic steatosis; Hepatitis B virus (HBV)

Indexed keywords

ALANINE AMINOTRANSFERASE; DNA; HEPATITIS B(E) ANTIGEN;

ADULT; ARTICLE; ASIAN AMERICAN; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AGE FACTORS; AGED; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ASIAN AMERICANS; ASPARTATE AMINOTRANSFERASES; CARCINOMA, HEPATOCELLULAR; DNA, VIRAL; FATTY LIVER; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SMOKING; YOUNG ADULT;

EID: 77951749867     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181b5c7a8     Document Type: Article

References (37)

1. Lai CL, Yeun MF. The natural history and treatment of chronic hepatitis B: a critical evaluation of standard treatment criteria and end points. Ann Intern Med. 2007;147:58-61.
2. Hu KQ. Hepatitis B virus (HBV) infection in the Asian and Pacific Islander Americans (APIAs): how can we do better for this special population? Am J Gastroenterol. 2008;103: 1824-1833.
3. Pollack H, Wan K, Ramos R, et al. Screening for chronic hepatitis B among Asian/Pacific Islander Populations - New York City, 2005. MMWR. 2006;55:505-509.
4. Custer B, Sullivan SD, Hazlet TK, et al. Global epidemiology of hepatitis B virus. J Clin Gastroenterol. 2004;38(suppl 10): S158-S168.
5. Alter MJ, Hadler SC, Margolis HS, et al. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA. 1990;263:1218-1222.
6. McQuillan GM, Townsend TR, Fields HA, et al. Seroepidemiology of hepatitis B virus infection in the United States: 1976 to 1980. Am J Med. 1989;87:5S-10S.
7. Cohen C, Evans AA, London WT, et al. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepatology. 2008;15:12-13.
8. Lin SY, Chang ET, So SK. Why we should routinely screen Asian American adults for hepatitis B: a cross-sectional study of Asians in California. Hepatology. 2007;46:1034-1040.
9. U.S. Census Bureau. Asian and Pacific Islander Populations. Available at http://factfinder.census.gov/servlet/ACSSAFFF acts?-submenuId=factsheet-0&- sse=on. [Accessed on February 15, 2009].
10. United States Census Bureau. Available at http://www. census.gov/Press-Release/www/releases/archives/population/ 001720.html. [Accessed on February 15, 2009].
11. Kim WR, Benson JT, Threneau TM, et al. Changing epidemiology of hepatitis B in a U.S. community. Hepatology. 2004;39:811-816.
12. Hoofnagle JH, Doo E, Liang TJ, et al. Management of hepatitis B: Ssmmary of a clinical research workshop. Hepatology. 2007;45:1056-1075.
13. Yim HJ, Lok ASF. Natural history of chronic hepatitis B virus infection: what we know in 1981 and what we know in 2005. Hepatology. 2006;43:S173-S181.
14. Pan C, Jia JD, Chu C-J, et al. Epidemiology, presentation, and treatment of chronic HBV infection in Mainland China, in Taiwan, and in Chinese Americans in the United States. Curr Hepat B Rep. 2008;2:159-165.
15. Hann HW, Han SH, Block TM, et al. Symptomatology and health attitudes of chronic hepatitis B patients in the USA. J Viral Hepat. 2008;15:42-51.
16. Hann HW, Hann RS, Maddrey WC. Hepatitis B virus infection in 6130 unvaccinated Korean-Americans surveyed between 1988 and 1990. Am J Gastroenterol. 2007;102: 767-772.
17. Huang S, Shallow S, Stier D, et al. Characteristics of persons with chronic hepatitis B - San Francisco, California, 2006. MMWR Morb Mortal Wkly Rep. 2007;56:446-448.
18. Wong WW, Minuk GY. A cross-sectional seroepidemiologic survey of chronic hepatitis B virus infections in southeast Asian immigrants in a Canadian urban centre. Clin Invest Med. 1994; 17:443-447.
19. Lok ASF, McMahon BJ. Chronic hepatitis B. Hepatology. 2007;45:507-539.
20. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236.
21. Hu K-Q, Kyulo N, Esrailian E, et al. Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a large cohort study in the United States. J Hepatol. 2004; 40:147-154.
22. Hu K-Q, Kyulo N, Lim N, et al. Clinical significance of elevated alpha fetoprotein (AFP) in patients with chronic hepatitis C, but not hepatocellular carcinoma. Am J Gastroenterol. 2004;99:860-865.
23. Yuen MF, Wong DK, Sablon E, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology. 2004;39:1694-1701.
24. Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133: 1452-1457.
25. Chen C-J, Yang H-I, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006;295:65-73.
26. Chu CM, Liaw YF. Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus. Am J Gastroenterol. 2009;104:1693-1699.
27. Yuen MF, Yuan HJ, Wong DK, et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut. 2005;54:1610-1614.
28. Shi JP, Fan JG, Lou GQ, et al. Hepatic steatosis: a common reason for elevated alanine aminotransferase levels in HBsAg-positive chronic hepatitis B patients with low HBV DNA loads. Zhonghua Gan Zang Bing Za Zhi. 2008;16: 818-822.
29. Thomopoulos KC, Arvaniti V, Tsamantas AC, et al. Prevalence of liver steatosis in patients with chronic hepatitis B: a study of associated factors and of relationship with fibrosis. Eur J Gastroenterol Hepatol. 2006;18:233-237.
30. Cleibel W, Hussain G, Lai M, et al. High prevalence of hepatic steatosis and its impact on fibrosis in chronic hepatitis B. Hepatology. 2008;48(suppl): 677A.
31. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007; 132:2557-2576.
32. Surveillance, epidemiology, and end results program. http:// www.seer.cancer.gov/statfacts/html/livibd.html. [Accessed February 15, 2009].
33. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004; 127(suppl 1):S5-S16.
34. Wands J. Hepatocellular carcinoma and sex. N Engl J Med. 2007;357:1974-1976.
35. Kuper H, Tzonou A, Kaklamani E, et al. Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Cancer. 2000;85:498-502.
36. Naugler WE, Sakurai T, Kim S, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317:121-124.
37. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska Natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000;32:842-846.